Katsura Y, Kawaguchi S, Muramatsu S
Immunology. 1972 Oct;23(4):537-44.
Bone marrow cells and thymus cells were observed in cell transfer experiments to collaborate in the production of anti-BSA antibodies. The target cells for tolerance induction either with a low dose' of antigen (100 μg of deaggregated BSA once a week × 5) or with a high dose' (a single injection of 5000 μg) were identified by the same technique. In low dose' tolerance, some indication was obtained that thymus-derived cells in peripheral lymphoid systems were the target cells; bone marrow-derived cells appeared not to be so susceptible, and the cells residing in thymus or bone marrow seemed to remain unimpaired. In contrast, the injection of a high dose' of tolerogen rendered both types of cells in spleen, thymus cells and bone marrow cells, unresponsive or hyporesponsive in parallel with one another.
在细胞转移实验中观察到骨髓细胞和胸腺细胞协同产生抗牛血清白蛋白(BSA)抗体。采用相同技术确定了用“低剂量”抗原(每周100μg去聚合BSA,共5次)或“高剂量”(单次注射5000μg)诱导耐受的靶细胞。在“低剂量”耐受中,有迹象表明外周淋巴系统中源自胸腺的细胞是靶细胞;源自骨髓的细胞似乎不那么敏感,而位于胸腺或骨髓中的细胞似乎未受损害。相比之下,注射“高剂量”的致耐受原会使脾脏中的两种细胞,即胸腺细胞和骨髓细胞,彼此平行地无反应或反应低下。